Journal Articles
International Journal of Clinical Practice
Year : 2021
francis berenbaum : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03994596
Submitted on : Friday, February 17, 2023-3:46:00 PM
Last modification on : Thursday, December 14, 2023-1:50:38 PM
Cite
Francis Berenbaum, Thomas Schnitzer, Alan Kivitz, Lars Viktrup, Elizabeth Johnston, et al.. Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials. International Journal of Clinical Practice, 2021, 75 (12), ⟨10.1111/ijcp.14975⟩. ⟨hal-03994596⟩
Collections
3
View
0
Download